Piramal Phytocare (Delisted) financials and balance sheet

BSE: 532979

Formerly Piramal Life Sciences

Last traded ₹22.70 on 10 Dec 2019

Delisted on 27 May 2020.

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Piramal Phytocare annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹25 Cr, year to Mar 2019A loss in 9 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2019

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue25
  2. Materials and goods−7.5
  3. Employee costs−5.7
  4. Other expenses−19
  5. Operating profit−7.5
  6. Depreciation0.0
  7. Other income+0.1
  8. One-off items0.0
  9. Finance costs−0.8
  10. Profit before tax−8.2
  11. Tax0.0
  12. Net profit−8.2

What the company owns

  • Plant, investments and other assets₹6 Cr
  • Cash and bank₹1 Cr
  • Receivables₹1 Cr
  • Inventory₹0 Cr

What pays for it: net worth and liabilities

  • Owed to suppliers₹19 Cr
  • Borrowings₹13 Cr

Profit and loss

Standalone, ₹ crore, years to March.Piramal Phytocare quarterly results

₹ croreMar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Filed 8 May
Revenue from operations6163565642425
107109–8––––4633
Materials and goods bought32234222138
Employee costs–––1–––––6
Other expenses–––4–––––19
Operating profit before depreciation−101−93–−2––––−23−8
Operating margin−1,626.1%−585.5%–−45.2%––––−95.0%−29.9%
Materials, % of revenue–––49.6%–––––29.9%
Employee costs, % of revenue–––20.8%–––––22.5%
Other expenses, % of revenue–––75.6%–––––77.4%
Depreciation and amortisation111155–55000
Operating profit after depreciation−112−104–−7––––−23−8
Other income––01000000
Finance costs2539–0––––01
One-off items–––––––––0
Profit before tax−137−143−7−6−4−3−30−22−8
Tax−7––––––––0
Net profit−130−143−7−6−4−3−30−22−8
Other comprehensive income–––––––––0
Total comprehensive income–––––––––−8
Net margin−2,090.2%−899.2%−249.5%−121.4%−71.0%−76.2%−52.1%4.6%−94.4%−32.8%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2010, Mar 2011 and Mar 2018 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the years to Mar 2012, Mar 2015, Mar 2016 and Mar 2017: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2014: the statement does not state its finance costs or depreciation, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 8 May
−25.5
Share capital26.0
Reserves−51.5
Borrowings13.4
33.3
Liabilities due after a year0.2
Total assets7.9
0.6
7.4
Net debt12.4
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2010, Mar 2011, Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Filed 8 May
–––––––₹0.10−₹8.70–
As stated that year−₹51.00––––––₹0.10−₹8.70–
–––––––₹0.10−₹8.70–
Market cap at the year end (₹ crore)332272––––––––
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from. As stated that year and earnings per share are left blank for the year to Mar 2019: the earnings per share stated has the opposite sign to the profit stated beside it, so it is not shown.

Ratios

Standalone, years to March.

RatioMar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Filed 8 May
Revenue growth171.2%156.0%−82.1%83.9%13.7%−23.8%39.2%−34.7%476.5%5.5%
Return on equity–––––––––32.3%
Receivable days–––––––––9
Inventory days–––––––––6
Payable days–––––––––913
Cash conversion cycle, days–––––––––−898
Working capital days–––––––––−198
Asset turnover–––––––––3.16
Assets per rupee of net worth–––––––––−0.31
Sales per rupee of plant–––––––––93.04
Interest cover is left blank for the years to Mar 2010, Mar 2011, Mar 2013, Mar 2018 and Mar 2019: operating profit after depreciation is a loss, and a loss covers no interest bill. Debt to equity is left blank for the year to Mar 2019: net worth is below zero, so there is no shareholders' money to set the borrowings against. Return on capital employed is left blank for the year to Mar 2019: net worth and borrowings together come to nought or less, so there is no money employed to set the operating profit against. No balance sheet is on record for the years to Mar 2010, Mar 2011, Mar 2012, Mar 2013, Mar 2014, Mar 2015, Mar 2016, Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2019.

Return on assets, latest year
−103.8%
Measure10 years5 years3 years
Revenue growth, yearly rate27.1%33.3%58.4%
Operating margin, average––−62.5%
Net margin, average−368.2%−50.2%−40.9%

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2019
Altman Z-scorePublished threshold 1.1−49.74
A threshold marked as ours has no published figure; it is the line we read the check against.